LYMPHOMAP
LIVE

Serial Number

90523038

Owner

LYMPHOMAP Inc.

Attorney

Ranjini Acharya

First Use Date

Nov 21, 2022

Filing Date

Feb 10, 2021

Add to watchlist:

No watchlists yet
View on USPTO

LYMPHOMAP Trademark

Serial Number: 90523038 • Registration: 7355878

LYMPHOMAP is a trademark filed by LYMPHOMAP Inc. on February 10, 2021. The trademark is classified under Class 9 (Computers & Electronics), Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

LYMPHOMAP Inc. (3 trademarks)

Long Island City, NY 11101

Entity Type: 03

Trademark Details

Filing Date

February 10, 2021

Registration Date

April 9, 2024

First Use Anywhere

November 21, 2022

First Use in Commerce

November 21, 2022

Published for Opposition

October 19, 2021

Goods & Services

Downloadable computer programs using artificial intelligence for use in software development and machine learning in the field of healthcare; Recorded computer software using artificial intelligence for use in software development and machine learning in the field of healthcare; Software as a Medical Device (SaMD), downloadable, for diagnosing and treating cancer; Software as a Medical Device (SaMD), recorded, for diagnosing and treating cancer

Videoconferencing services

Business collaboration services, namely, providing a national computer-based networking web site for health care and medical researchers and educators to collaborate across disciplines to help improve health care education and medical education; Promoting collaboration within the scientific, research and medical communities to achieve advances in the field of healthcare; Promoting the exchange of information and resources within the scientific research and medical communities to achieve advances in the field of healthcare; Providing an on-line database providing business intelligence in the fields of medical devices, pharmaceuticals and life sciences

Medical assistance services in the nature of medical information provided to medical professionals from remote locations via the Internet and global computer networks through the use of archived medical images and a data storage and retrieval system; Providing a website featuring information in the field of the diagnosis and treatment of cancer; Providing an internet website for medical professionals and medical patients featuring medical information from remote locations via devices that feed information to the website that is processed, exchanged and accessed in real-time by users; Providing an internet website for medical professionals and medical patients featuring medical information from remote locations via electronic patient monitoring devices that feed information to the web site that can be accessed in real-time by medical professionals for purposes of monitoring and diagnosing medical conditions

Application service provider (ASP) featuring software using artificial intelligence for use in software development and machine learning in the field of healthcare; Medical and scientific research in the field of cancer treatment and diagnosis; Providing online non-downloadable computer programs for use in cancer diagnosis; Providing a website featuring non-downloadable software using artificial intelligence for use in software development and machine learning in the field of healthcare; Providing information about medical and scientific research via a website; Providing on-line non-downloadable software using artificial intelligence for use in cancer treatment and diagnosis; Software as a service (SAAS) services featuring software using artificial intelligence for use in cancer treatment and diagnosis; Software as a service (SAAS) services featuring software using artificial intelligence for use in software development and machine learning in the field of healthcare; Technology consultation in the field of artificial intelligence

Filing History

REGISTERED-PRINCIPAL REGISTER
Apr 9, 2024 R.PR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 9, 2024 NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 9, 2024 NRCC
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 7, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 6, 2024 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 5, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 5, 2024 CRFA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 5, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 5, 2024 CRFA
ASSIGNED TO LIE
Mar 5, 2024 ALIE
TEAS POST PUBLICATION AMENDMENT RECEIVED
Sep 13, 2023 EPPA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 17, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 22, 2023 GNRN
NON-FINAL ACTION E-MAILED
Feb 22, 2023 GNRT
SU - NON-FINAL ACTION - WRITTEN
Feb 22, 2023 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Jan 10, 2023 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 9, 2023 AITU
USE AMENDMENT FILED
Dec 8, 2022 IUAF
TEAS STATEMENT OF USE RECEIVED
Dec 8, 2022 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 27, 2022 EXRA
SOU EXTENSION 1 GRANTED
May 25, 2022 EX1G
SOU EXTENSION 1 FILED
May 25, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
May 25, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 14, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 19, 2021 NPUB
PUBLISHED FOR OPPOSITION
Oct 19, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 29, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 11, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 11, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 11, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 11, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 11, 2021 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 11, 2021 GNRN
NON-FINAL ACTION E-MAILED
Sep 11, 2021 GNRT
NON-FINAL ACTION WRITTEN
Sep 11, 2021 CNRT
ASSIGNED TO EXAMINER
Sep 5, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 14, 2021 NWOS
NEW APPLICATION ENTERED
Feb 15, 2021 NWAP